Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CMV-CTL for CMV Infection After Allogeneic HSCT
NCT03004261Phase 4Completed
- Sponsor
- Shanghai General Hospital
- Start
- Nov 2016
- Primary completion
- Dec 2021
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 4 trial of donor-derived cytomegalovirus-specific cytotoxic T lymphocytes in cytomegalovirus infection (CMV), sponsored by Shanghai General Hospital. Started Nov 2016; status: completed.
02
Drugs
donor-derived cytomegalovirus-specific cytotoxic T lymphocytes
03
Conditions
cytomegalovirus infection (CMV)
Beyond the preview
Go deeper on NCT03004261.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03004261.